PL423266A1 - Sposób diagnozowania nowotworów układu chłonnego - Google Patents

Sposób diagnozowania nowotworów układu chłonnego

Info

Publication number
PL423266A1
PL423266A1 PL423266A PL42326617A PL423266A1 PL 423266 A1 PL423266 A1 PL 423266A1 PL 423266 A PL423266 A PL 423266A PL 42326617 A PL42326617 A PL 42326617A PL 423266 A1 PL423266 A1 PL 423266A1
Authority
PL
Poland
Prior art keywords
cells
lymphatic system
system neoplasms
diagnosing
diagnosing lymphatic
Prior art date
Application number
PL423266A
Other languages
English (en)
Other versions
PL237087B1 (pl
Inventor
Kamila Duś-Szachniewicz
Marta WOŹNIAK
Krzysztof ZDUNIAK
Kinga WALASZEK
Sławomir DROBCZYŃSKI
Original Assignee
Univ Medyczny Im Piastow Slaskich We Wroclawiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Medyczny Im Piastow Slaskich We Wroclawiu filed Critical Univ Medyczny Im Piastow Slaskich We Wroclawiu
Priority to PL423266A priority Critical patent/PL237087B1/pl
Priority to PCT/PL2018/000103 priority patent/WO2019083383A1/en
Priority to EP18869602.5A priority patent/EP3701265A4/en
Publication of PL423266A1 publication Critical patent/PL423266A1/pl
Publication of PL237087B1 publication Critical patent/PL237087B1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób identyfikacji komórek prawidłowych i komórek nowotworowych w chorobach przerostowych układu chłonnego. Sposób polega na tym, że pozwala na detekcję prawidłowych limfocytów B i komórek chłoniaków nieziarniczych na podstawie czasu potrzebnego do utworzenia stabilnej kokultury z komórkami zrębu szpiku kostnego przez oba typy komórek. Sposób może być realizowany z wykorzystaniem techniki szczypiec optycznych.
PL423266A 2017-10-25 2017-10-25 Sposób diagnozowania nowotworów układu chłonnego PL237087B1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL423266A PL237087B1 (pl) 2017-10-25 2017-10-25 Sposób diagnozowania nowotworów układu chłonnego
PCT/PL2018/000103 WO2019083383A1 (en) 2017-10-25 2018-10-25 DIAGNOSTIC METHOD FOR NEOPLASMS OF LYMPHOID TISSUE
EP18869602.5A EP3701265A4 (en) 2017-10-25 2018-10-25 METHOD OF DIAGNOSIS OF NEOPLASMS FROM LYMPHOID TISSUE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL423266A PL237087B1 (pl) 2017-10-25 2017-10-25 Sposób diagnozowania nowotworów układu chłonnego

Publications (2)

Publication Number Publication Date
PL423266A1 true PL423266A1 (pl) 2019-05-06
PL237087B1 PL237087B1 (pl) 2021-03-08

Family

ID=66246592

Family Applications (1)

Application Number Title Priority Date Filing Date
PL423266A PL237087B1 (pl) 2017-10-25 2017-10-25 Sposób diagnozowania nowotworów układu chłonnego

Country Status (3)

Country Link
EP (1) EP3701265A4 (pl)
PL (1) PL237087B1 (pl)
WO (1) WO2019083383A1 (pl)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102747156A (zh) * 2012-07-13 2012-10-24 中国医学科学院肿瘤医院 Bcl-2/IgH基因重排在作为B细胞淋巴瘤骨髓浸润标志中的应用
CN104931699A (zh) * 2015-05-29 2015-09-23 北京海思特临床检验所有限公司 骨髓涂片异常淋巴细胞染色试剂盒及其使用方法
WO2016154620A1 (en) * 2015-03-26 2016-09-29 University Of Houston System Integrated functional and molecular profiling of cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038145A (en) 1974-07-08 1977-07-26 Mead Johnson & Company Malignancy diagnostic method
KR101781638B1 (ko) 2007-07-25 2017-09-25 필로겐 에스.피.에이. 종양 전이의 신생혈관과 관련된 피브리노겐의 ｅｄ-ａ 항원
US20110293558A1 (en) 2010-03-22 2011-12-01 Massachusetts Institute Of Technology Material properties of t cells and related methods and compositions
DE102010041912B3 (de) 2010-10-04 2012-04-12 Universität Leipzig Verfahren zur Diagnose und/oder Prognose von Krebserkrankungen durch Analyse der mechanischen Eigenschaften von Tumorzellen
CN103596974B (zh) 2011-04-15 2016-08-31 卡姆普根有限公司 多肽和多核苷酸及其用于治疗免疫相关失调和癌症的用途
JP6805137B2 (ja) 2014-07-11 2020-12-23 アンセルム（アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル） 血液学的癌を診断するための方法
CA2968002A1 (en) 2014-11-17 2016-05-26 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods of diagnosing cancer and of predicting response of cancer to dendrogenin a treatment

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102747156A (zh) * 2012-07-13 2012-10-24 中国医学科学院肿瘤医院 Bcl-2/IgH基因重排在作为B细胞淋巴瘤骨髓浸润标志中的应用
WO2016154620A1 (en) * 2015-03-26 2016-09-29 University Of Houston System Integrated functional and molecular profiling of cells
CN104931699A (zh) * 2015-05-29 2015-09-23 北京海思特临床检验所有限公司 骨髓涂片异常淋巴细胞染色试剂盒及其使用方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DONATE C, HOMING OF HUMAN B CELLS TO LYMPHOID ORGANS AND B-CELI LYMPHOMA ENGRAFTMENT ARE CONTROLLED BY CELI ADHESION MOLECULE JAM-C, January 2013 (2013-01-01) *

Also Published As

Publication number Publication date
EP3701265A4 (en) 2021-07-07
PL237087B1 (pl) 2021-03-08
EP3701265A1 (en) 2020-09-02
WO2019083383A1 (en) 2019-05-02

Similar Documents

Publication Publication Date Title
CY1119763T1 (el) Υποδοχεας ουρων για γυναικες
SG10201806890VA (en) Massively parallel single cell analysis
WO2018213661A3 (en) PASSIVATION AGENTS FOR ELECTROCHEMICAL CELLS
BR112017009151A2 (pt) ensaios para detectar subgrupos imunológicos de célula t e métodos de uso dos mesmos
BR112018008293A2 (pt) expansão de células t gama delta não hematopoiéticas residentes no tecido e o uso dessas células
MY164570A (en) Method and system for integration of clinical and facilities management systems
BR112018003969A2 (pt) plataforma de aplicativo de célula pequena
TR201900776T4 (tr) Memeli hücre kültürlerinin hasadına ilişkin yöntem.
DE602006019476D1 (de) Verwendung von filterung und aktiver prüfung zur evaluierung eines datentransferweges
AR090017A1 (es) Agonistas de fgfr1 y sus metodos de uso
RS54073B1 (en) STROMAL MATERIAL CELLS
BR112015010544A2 (pt) processamento de lotes descontínuos alimentados com o uso de biorreatores alternados
CY1120220T1 (el) Μεθοδοι και κυτια για προσδιορισμο της καταστασης λοιμωξης απο φυματιωση
MX2019002578A (es) Métodos de detección de la expresión del ligando 1 de muerte programada por célula y usos de los mismos.
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
MX366777B (es) Metodo y aparato para analisis y gestion de relaciones sociales.
MX2015018035A (es) Metodos para predecir respuestas a sustancias quimicas o biologicas.
GB2574988A (en) Neuromuscular junction: NMJ-on-chip
BR112017017886A2 (pt) gerando populações de células endoteliais arteriais
FR2918079B1 (fr) Procede et un dispositif d'extraction selective de cations par transfert electrochimique en solution et applications de ce procede.
CL2020002715A1 (es) Composiciones y métodos para tratar la endometriosis
MX2015001717A (es) Metodo para la deteccion directa de mycobacterium tuberculosis.
GB2508782A (en) Facile laboratory method for localising biomolecules to the surface of cells and viruses
WO2012170939A3 (en) Identifying hierarchical chip design intellectual property through digests
PL423266A1 (pl) Sposób diagnozowania nowotworów układu chłonnego